OTC:VICP | Free Cash Flow | Vicapsys Life Sciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-03-31 to 2024-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2024-03-31-$9,422.00
2023-12-31-$82,054.00
2023-03-31-$9,957.00
2022-12-31$2,888.00
2022-03-31-$115,976.00
2021-12-31-$123,254.00
2021-03-31-$70,806.00
2020-12-31-$385.00
2020-03-31-$233,218.00
2019-12-31-$246,480.00
2019-03-31-$187,738.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2023-12-31-$417,524.00
2022-12-31-$238,197.00
2021-12-31-$443,974.00
2020-12-31-$262,897.00
2019-12-31-$970,264.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.